Publication | Open Access

Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib

OncologyRegorafenib ActivityGastrointestinal OncologyMedicineColorectal CancerPathologyCancer TreatmentPharmacologyTumor MicroenvironmentCancer Research